AZN Related Momentum Movers
-
Optimer Pharma (OPTR) Said to Draw Interest from Glaxo (GSK), Astellas
-
Rigel Pharma (RIGL) Hit as OSKIRA-4 Misses Secondary Endpoint (AZN)
-
Amarin (AMRN) Is 'In Play'
-
Analysts Expecting Higher Bids for Amylin (AMLN)
-
Targacept (TRGT) Slammed Following RENAISSANCE Phase 3 Endpoint Miss
-
AstraZeneca (AZN) Slumps as FDA Requests Additional PLATO Data for BRILINTA
-
AstraZeneca (AZN) said to seek $2B sale of Astra Tech unit -Bloomberg
-
Nektar Therapeutics (NKTR) Enters Worldwide Agreement With AstraZeneca (AZN) for NKTR-118 and NKTR-119
-
Natixis Bleichroeder Lifts Price Target on Targacept (TRGT) to $7.50
-
Targacept (TRGT) To Receive $10M Payment From AstraZeneca Due To Further Development of AZD3480
-
Palatin Technologies (PTN) Higher On Collaboration Deal with AstraZeneca
Back to AZN Stock Lookup
